Efficacy News and Research

RSS
Vivus receives FDA approval for Qsymia to manage chronic weight

Vivus receives FDA approval for Qsymia to manage chronic weight

Medica releases EasyCell solution for hematology laboratories

Medica releases EasyCell solution for hematology laboratories

Jade, BioTime sign exclusive sublicense and supply agreement for HyStem

Jade, BioTime sign exclusive sublicense and supply agreement for HyStem

Computerized mobilization eases chronic neck pain

Computerized mobilization eases chronic neck pain

UIC develops new tool to guide decisions about safe and effective medication use

UIC develops new tool to guide decisions about safe and effective medication use

U.S. FDA approves Gilead’s Truvada to minimize risk of sexually-acquired HIV infection

U.S. FDA approves Gilead’s Truvada to minimize risk of sexually-acquired HIV infection

AstraZeneca plans to conduct ticagrelor plus clopidogrel clinical trial for PAD

AstraZeneca plans to conduct ticagrelor plus clopidogrel clinical trial for PAD

PsychoGenics, Afraxis partner to offer Enhanced Spine Platform technology

PsychoGenics, Afraxis partner to offer Enhanced Spine Platform technology

Ampio announces advancement of NCE001 to preclinical development

Ampio announces advancement of NCE001 to preclinical development

D-ribose effective in improving QOL in energy-depleted patients with FMS/CFS

D-ribose effective in improving QOL in energy-depleted patients with FMS/CFS

Once-daily single-tablet HIV therapy developed

Once-daily single-tablet HIV therapy developed

Merck to present results from clinical studies on BACE inhibitors at AAIC 2012

Merck to present results from clinical studies on BACE inhibitors at AAIC 2012

Polio eradication: an interview with Dr. Kathleen O’Reilly

Polio eradication: an interview with Dr. Kathleen O’Reilly

UCB’s Neupro now available in U.S. pharmacies

UCB’s Neupro now available in U.S. pharmacies

New paper documents discovery of novel lipids, including MC3

New paper documents discovery of novel lipids, including MC3

EU-funded researchers develop new antimicrobial resistance monitoring solution

EU-funded researchers develop new antimicrobial resistance monitoring solution

OncoMed commences dosing in OMP-54F28 Phase I clinical trial for advanced solid tumor cancers

OncoMed commences dosing in OMP-54F28 Phase I clinical trial for advanced solid tumor cancers

Cubist initiates CB-315 Phase 3 trial for Clostridium difficile-associated diarrhea

Cubist initiates CB-315 Phase 3 trial for Clostridium difficile-associated diarrhea

Pressure Point develops 72 hour low-cost dermal device to effectively reduce PONV

Pressure Point develops 72 hour low-cost dermal device to effectively reduce PONV

Eschar-derived cells may be used for tissue engineering

Eschar-derived cells may be used for tissue engineering

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.